4.0 out of 5 stars
(4 Ratings)
A trade services platform designed to adapt to evolving compliance, client needs, and competitive pressures offers a digitized, intelligent, and open approach to trade. It allows users to digitize and manage negotiable instruments and documents of title without relying on a central registry. By automating the review of documents under a Letter of Credit, organizations can save time and lessen risk. Appzillon enables corporate treasurers and finance heads to approve and oversee transactions on the go through mobile devices. By transitioning from traditional digital methods to conversational banking, businesses can enhance the corporate customer experience through multi-channel interactions. The conventional trade processing system has long relied on paper, but recent sustainability initiatives have prompted a shift away from physical documents in favor of more automated, efficient processes that also mitigate fraud risk. This shift has gained momentum due to the pandemic, leading to a heightened demand for digital solutions and a growing expectation that customers should be able to conduct all their transactions from home. As organizations embrace these changes, they position themselves for a more agile and resilient future.
Learn more about Finastra Trade Innovation
4.4 out of 5 stars
(1629 Ratings)
Customer experience shouldn't run on disconnected tools and static scripts. Dialpad Contact Center brings voice, digital channels, and human agents together in a single AI-native platform, built to act — not just record — on every customer interaction.
This is Agentic AI in practice: agents that reason through a problem, take the next step, and drive it to resolution without waiting on a human to intervene. Where legacy systems leave data trapped in silos, Dialpad Contact Center closes that gap, linking voice and data so context travels with the customer instead of getting lost between systems.
The payoff compounds. Dialpad has already generated over 775 million AI recaps, and each new interaction adds to a growing base of operational intelligence — sharper resolution paths, more productive agents, better outcomes quarter over quarter. None of it runs unchecked: Dialpad's Guardian layer keeps AI operations secure and governed, so intelligence scales without sacrificing oversight.
In practice, that means up to 80% of issues get resolved autonomously, freeing your team to focus on the conversations that genuinely need a human. Intelligence works at the edge; people stay at the center of the experience.
And you don't have to take the ROI on faith. Through Dialpad's Proving Ground, enterprises can validate performance and cost savings before rolling out at scale — a far more reliable path than betting on a brittle, rules-based bot.
Learn more about Dialpad Support
Genedata Biologics
Genedata Biologics® enhances the development of biotherapeutics, including bispecifics, ADCs, TCRs, CAR-Ts, and AAVs, providing a comprehensive solution for the industry. Recognized as the leading platform in the field, it seamlessly unifies all discovery workflows, allowing researchers to prioritize genuine innovation. By utilizing a pioneering platform that was purposefully created to digitalize the biotherapeutic discovery process, research can be accelerated significantly. The platform simplifies intricate R&D tasks by facilitating the design, tracking, testing, and evaluation of novel biotherapeutic drugs. It is compatible with various formats, such as antibodies, bi- or multi-specifics, ADCs, innovative scaffolds, and therapeutic proteins, as well as engineered therapeutic cell lines like TCRs and CAR-T cells. Functioning as a comprehensive end-to-end data backbone, Genedata Biologics connects all R&D processes, including library design, immunization, selection and panning, molecular biology, screening, protein engineering, expression, purification, and protein analytics, ultimately leading to thorough assessments of candidate developability and manufacturability. This holistic integration ensures that researchers can make informed decisions and push the boundaries of biotherapeutic innovation effectively.
Learn more about Genedata Biologics
QIAGEN Ingenuity Pathway Analysis
IPA can also help analyze small-scale experiments that produce gene and chemical lists. IPA allows for targeted searches on genes, chemicals, and drugs. It also allows the creation of interactive models of experimental system. Data analysis and search capabilities allow for the understanding of the significance of data, targets, or candidate biomarkers within larger biological or chemical systems. The Ingenuity Knowledge Base contains highly structured, detail-rich chemical and biological findings that backs the software. Learn more about QIAGEN Ingenuity Pathway Analysis. Comparison Analysis determines which pathways, upstream regulators and diseases are most important. It can also be used to identify biological functions across time, doses, and other conditions.
Learn more about QIAGEN Ingenuity Pathway Analysis